CONTEXT: Disruption of the Gsα maternal allele leads to severe obesity and insulin resistance in mice and early-onset obesity in patients with pseudohypoparathyroidism (PHP) type 1a. However, insulin resistance and glucose metabolism have not been systematically characterized in patients with PHP1a. OBJECTIVE, DESIGN, AND SETTING: In a cross-sectional, case-control study, we examined insulin sensitivity, β-cell function, energy expenditure (EE), and sympathetic nervous system activity in adults with PHP1a. STUDY PARTICIPANTS: PHP1a patients (n = 8) and healthy control subjects (n = 24) matched for age (41 ± 7 vs 41 ± 7 years [mean ± SD]), gender, and percent body fat. METHODS: Insulin sensitivity (SI), acute insulin response to glucose, and disposition index were assessed during a frequently sampled iv glucose tolerance test. Oral glucose insulin sensitivity (OGIS) was measured during a mixed meal. EE was measured using whole-room indirect calorimetry. Body composition was assessed via dual-energy x-ray absorptiometry and sympathetic nervous system activity by measuring 24-hour urinary catecholamine concentrations. RESULTS: PHP1a patients were less insulin-sensitive than their matched controls based upon SI and OGIS. Nondiabetic PHP1a patients tended to have a lower SI (P = .09) and reduced OGIS (P = .03). Disposition index, a composite measure of β-cell function, also tended to be lower in patients (P = .07). Total caloric intake, resting EE, total EE, meal-induced thermogenesis, and 24-hour urinary catecholamine concentrations were not significantly different between the groups. CONCLUSIONS: Adults with PHP-1a have reduced insulin sensitivity compared with their matched controls that may contribute to the pathogenesis of glucose intolerance and diabetes in these patients.
CONTEXT: Disruption of the Gsα maternal allele leads to severe obesity and insulin resistance in mice and early-onset obesity in patients with pseudohypoparathyroidism (PHP) type 1a. However, insulin resistance and glucose metabolism have not been systematically characterized in patients with PHP1a. OBJECTIVE, DESIGN, AND SETTING: In a cross-sectional, case-control study, we examined insulin sensitivity, β-cell function, energy expenditure (EE), and sympathetic nervous system activity in adults with PHP1a. STUDY PARTICIPANTS: PHP1a patients (n = 8) and healthy control subjects (n = 24) matched for age (41 ± 7 vs 41 ± 7 years [mean ± SD]), gender, and percent body fat. METHODS:Insulin sensitivity (SI), acute insulin response to glucose, and disposition index were assessed during a frequently sampled iv glucose tolerance test. Oral glucose insulin sensitivity (OGIS) was measured during a mixed meal. EE was measured using whole-room indirect calorimetry. Body composition was assessed via dual-energy x-ray absorptiometry and sympathetic nervous system activity by measuring 24-hour urinary catecholamine concentrations. RESULTS: PHP1a patients were less insulin-sensitive than their matched controls based upon SI and OGIS. Nondiabetic PHP1apatients tended to have a lower SI (P = .09) and reduced OGIS (P = .03). Disposition index, a composite measure of β-cell function, also tended to be lower in patients (P = .07). Total caloric intake, resting EE, total EE, meal-induced thermogenesis, and 24-hour urinary catecholamine concentrations were not significantly different between the groups. CONCLUSIONS: Adults with PHP-1a have reduced insulin sensitivity compared with their matched controls that may contribute to the pathogenesis of glucose intolerance and diabetes in these patients.
Authors: Min Chen; Oksana Gavrilova; Jie Liu; Tao Xie; Chuxia Deng; Annie T Nguyen; Lisa M Nackers; Javier Lorenzo; Laura Shen; Lee S Weinstein Journal: Proc Natl Acad Sci U S A Date: 2005-05-09 Impact factor: 11.205
Authors: J C Carel; C Le Stunff; L Condamine; E Mallet; J L Chaussain; P Adnot; M Garabédian; P Bougnères Journal: J Clin Endocrinol Metab Date: 1999-11 Impact factor: 5.958
Authors: Dominique N Long; Sarah McGuire; Michael A Levine; Lee S Weinstein; Emily L Germain-Lee Journal: J Clin Endocrinol Metab Date: 2006-12-12 Impact factor: 5.958
Authors: Emily L Germain-Lee; Joshua Groman; Janet L Crane; Suzanne M Jan de Beur; Michael A Levine Journal: J Clin Endocrinol Metab Date: 2003-09 Impact factor: 5.958
Authors: Josina M Rijkelijkhuizen; Cynthia J Girman; Andrea Mari; Marjan Alssema; Thomas Rhodes; Giel Nijpels; Piet J Kostense; Peter P Stein; Elisabeth M Eekhoff; Robert J Heine; Jacqueline M Dekker Journal: Diabetes Res Clin Pract Date: 2008-12-20 Impact factor: 5.602
Authors: Kathleen L Curley; Sachini Kahanda; Katia M Perez; Beth A Malow; Ashley H Shoemaker Journal: Horm Res Paediatr Date: 2018-02-16 Impact factor: 2.852
Authors: Katia M Perez; Kathleen L Curley; James C Slaughter; Ashley H Shoemaker Journal: J Clin Endocrinol Metab Date: 2018-11-01 Impact factor: 5.958
Authors: Jeffrey D Roizen; Jennifer Danzig; Veronique Groleau; Shana McCormack; Alex Casella; Jennifer Harrington; Etienne Sochett; Andrew Tershakovec; Babette S Zemel; Virginia A Stallings; Michael A Levine Journal: J Clin Endocrinol Metab Date: 2015-12-28 Impact factor: 5.958
Authors: Alta Berger; Ahmed Kablan; Catherine Yao; Thuy Ho; Brandon Podyma; Lee S Weinstein; Min Chen Journal: Endocrinology Date: 2015-12-15 Impact factor: 4.736